Latest News in the Business and Financial World

Tuesday, April 13, 2021
Log in
  • Home
  • Company News & Financials
  • OTC Markets
  • Tech & Science
  • Health & LifeStyle
  • About WS OTC
    • Analysts & Contributors
    • Contact Us
    • Advertising
    • Feedback
    • Privacy Policy GDPR
  • Mobile
  • Latest News
    • New Theories Explain the Disappearance of the Mayan Civilization
    • What Happens If Coral Reefs Die?
    • Monsanto Loses Lawsuit for its Herbicide Products
    • Mankind (MNKD) shares Plunge after FDA Approves Afrezza, inhaled Insulin for Diabetes patients
    • Psychologists Confirm that Violent Video Games Boost Aggressiveness
    • World of Warcraft: Warlords of Draenor Release Date on Nov 13
    • iPass Global Hotspot Map Unveils Worldwide Wi-fi Coverage

Pages

  • About Wall Street OTC
  • Advertising
  • Analysts & Contributors
  • Contact
  • Feedback
  • Mobile
  • Privacy Policy GDPR
  • Terms of Service

Recent Posts

  • SF Hospital Slaps New Parents with $19K Bill for Baby Treatment
  • Furious Trump Blasts Harley-Davidson for Moving Production Overseas
  • Warning! MRI Machines Could Poison You
  • Flight Attendants More Likely to Get Certain Cancers
  • More Red Meat Allergy Cases Related to Lone Star Tick Bites

Hepatitis C Drug Makers Start Price War Although They Promised Not To

Jan 9, 2015 By Christina Langfold 1 Comment

Email, RSS Follow

AbbVie Inc. and Gilead Sciences Inc., the only hepatitis C drug makers , have already begun offering consistent discounts on their products to health insurance providers across the U.S. Both companies said last year that they weren’t planning get involved in a price war in 2015. However, business is business.

Yesterday, Anthem Inc, the most important provider of health insurance plans in the U.S., said that it had struck a deal with one of the two drug makers in exchange of cheaper hepatitis C drugs. Anthem Inc is the third insurer to publicly announce an exclusive deal with one of the pharma companies.

Still, it is not certain if such deals led to lower prices in other best-selling drugs such as treatments for heart disease, multiple sclerosis, cancer or rheumatism. During the JPMorgan Healthcare Conference in San Francisco, which will be held next week, health care investors will discuss hot topics including how far should the drug price war should go.

John Milligan, Gilead President, said in 2013, that pricing was a differentiating feature of Gilead’s drugs only in rare cases. He also said that people wouldn’t risk taking cheaper drugs that are less effective. So, Mr. Milligan concluded, low pricing strategies to gain market share would “probably” not work in that area.

Also, Richard Gonzalez, CEO of AbbVie, said in April that cutting prices to get more consumers was not his company’s strategy.

Despite such claims, both companies eventually engaged in the price war. Express Scripts Holding Co. said it closed a deal with AbbVie in December – the biotech company offered price discounts while Express Scripts Holding promised to promote the hepatitis C drug among most patients for more than 2 years.

Right away, Gilead closed two mutual beneficial deals with CVS Health Corp and Anthem on Harvoni drug. Yesterday, Anthem said that in order to get on the list of covered drugs, Gilead proposed discounts in return.

Both Gilead and Abbvie refused to comment.

Roger Longman, CEO of Real Endpoints LLC, said that Gilead-Abbvie price war was the first of its kind in specialty pharmaceuticals area.

Anthem’s business plans cover nearly 17 million Americans, while Express Scripts’ plans involve 8 million more.

Mr. Longman also said that we were going to see similar price wars in other drug categories such as cancer and rheumatoid arthritis medication.

Insurers, health providers and lawmakers have been criticizing Gilead and Abbvie for their overpriced hepatitis C drugs. Sovaldi, Gilead’s first hepatitis C drug, costs 84,000 for 12 weeks, Harvoni, Gilead’s improved hepatitis C drug, costs nearly $95,000 for a 12-week course of treatment, while Abbvie’s Viekira Pak costs $83,319 for a 12-week-long treatment.

Image Source: Fool

Email, RSS Follow
The following two tabs change content below.
  • Bio
  • Latest Posts

Christina Langfold

Remember that weird girl in school who never quite managed to fit in? Who was always silent and strange? That was me during my entire teenage life. A few years after finishing college (with a degree in arts) I decided that the best way to become more sociable, while also feeling safe, is to test my people skills online.

Latest posts by Christina Langfold (see all)

  • Scientists Discover the Second Fastest Spinning Pulsar In The Universe - Sep 9, 2017
  • Coral Reef Damage Scares Florida Keys Researchers and Businesses - Jun 26, 2017
  • Nike to Slash Global Workforce by 1,400 - Jun 16, 2017

Filed Under: Health & LifeStyle Tagged With: Abbvie, drug price wars, Gilead Sciences Inc., Harvoni price cut, hepatitis C drug, Hepatitis C Drug Makers, John Milligan, price war, Viekira Pak price discount

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 72 other subscribers

Mom holding newborn's hands

SF Hospital Slaps New Parents with $19K Bill for Baby Treatment

Jun 29, 2018 By Anne-Marie Jackson Leave a Comment

Harley-Davidson biker

Furious Trump Blasts Harley-Davidson for Moving Production Overseas

Jun 28, 2018 By Anne-Marie Jackson Leave a Comment

MRI machine

Warning! MRI Machines Could Poison You

Jun 27, 2018 By Anne-Marie Jackson Leave a Comment

Flight Attendants More Likely to Get Certain Cancers

Jun 27, 2018 By Anne-Marie Jackson Leave a Comment

Lone star tick sitting on a succulent leaf

More Red Meat Allergy Cases Related to Lone Star Tick Bites

Jun 26, 2018 By Anne-Marie Jackson Leave a Comment

Time magazine cover

Time Admits Sobbing Cover Girl Was Not Separated from Parents

Jun 26, 2018 By Anne-Marie Jackson Leave a Comment

Sunshine and green leaves

Vitamin D Deficiency Could Boost Risk of Lung Disease

Jun 25, 2018 By Anne-Marie Jackson Leave a Comment

Green-light laser pointer

Greek Boy’s Retina Severely Damaged by Laser Pointer

Jun 22, 2018 By Anne-Marie Jackson Leave a Comment

Red Tesla car

Tesla Suing ‘Whistleblower’ over Data Theft

Jun 21, 2018 By Anne-Marie Jackson Leave a Comment

Boiled eggs and mayonnaise

Eating too Clean Can Lead to Orthorexia

Jun 20, 2018 By Anne-Marie Jackson Leave a Comment

NYC mayor Bill de Blasio

NYC Will Allow People to Smoke Pot in Public

Jun 20, 2018 By Anne-Marie Jackson Leave a Comment

A kitten and a puppy sleeping in a bed while hugging each other

Who Is Smarter Between Cats and Dogs? Researchers Have an Answer (Study)

Jun 19, 2018 By Anne-Marie Jackson Leave a Comment

Orthodox church in Greece

Being Religious Is Tied to Longer Lifespan, Study

Jun 19, 2018 By Anne-Marie Jackson Leave a Comment

Bacon and eggs for breakfast

How Does the Keto Diet Work?

Jun 18, 2018 By Anne-Marie Jackson Leave a Comment

Related Articles

  • Mom holding newborn's hands

    SF Hospital Slaps New Parents with $19K Bill for Baby Treatment

    Jun 29, 2018
  • MRI machine

    Warning! MRI Machines Could Poison You

    Jun 27, 2018
  • Lone star tick sitting on a succulent leaf

    More Red Meat Allergy Cases Related to Lone Star Tick Bites

    Jun 26, 2018
  • Sunshine and green leaves

    Vitamin D Deficiency Could Boost Risk of Lung Disease

    Jun 25, 2018
  • Green-light laser pointer

    Greek Boy’s Retina Severely Damaged by Laser Pointer

    Jun 22, 2018
  • Boiled eggs and mayonnaise

    Eating too Clean Can Lead to Orthorexia

    Jun 20, 2018
  • Orthodox church in Greece

    Being Religious Is Tied to Longer Lifespan, Study

    Jun 19, 2018
  • Office workers

    Free Workplace Food Is Packed with Empty Calories (Study)

    Jun 13, 2018
  • Basil leaves in a wooden spoon next to some cherry tomatoes

    Plant Foods Are the Secret to Longevity and a Healthy Life

    Jun 12, 2018
  • hotel room

    Scientists Paying Volunteers $3,500 to Stay at ‘Flu Hotel’

    Jun 11, 2018

Categories

  • Business
  • Company News & Financials
  • Diversified Financial
  • Entertainment
  • Featured
  • Health & LifeStyle
  • Micro Cap
  • Mid Cap
  • National News
  • Nature
  • OTC Exchange
  • OTC Markets
  • OTC Research
  • Science
  • Small Cap
  • Sports
  • Tech & Science
  • U.S.
  • Uncategorized
  • Wall Street
  • World
  • World Indexes

Copyright © 2021 wallstreetotc.com

About · Privacy Policy · Sitemap · Terms of Service · Contact